1 in 7 U.S. High School Students Now Vapes
THURSDAY, Oct. 6, 2022 (HealthDay News) — Teen vaping continues at concerning levels, U.S. health officials reported Thursday. About 2.5 million middle school and high school students reported that they had vaped in the past 30 days in 2022, accordi…
Learn MoreFish Oil Could Strengthen Your Aging Brain
THURSDAY, Oct. 6, 2022 (HealthDay News) — Fish has been dubbed “brain food,” and a new study suggests that may really be true for middle-aged adults.Researchers found that among more than 2,000 middle-aged people, those with higher blood levels of om…
Learn MoreAI Can Identify Multisystem Inflammatory Syndrome in Children
THURSDAY, Oct. 6, 2022 (HealthDay News) — A deep-learning algorithm called KIDMATCH can distinguish between multisystem inflammatory syndrome in children (MIS-C), Kawasaki disease, and other similar febrile illnesses in children, according to a study…
Learn MoreResponse to Neoadjuvant Chemo for Breast Cancer Varies by Sex
THURSDAY, Oct. 6, 2022 (HealthDay News) — Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) are numerically lower in men with breast cancer (BC) versus women with BC for each tumor subtype, according to…
Learn MoreAAO: One in Nine Patients With Wet AMD Skip Follow-Up
THURSDAY, Oct. 6, 2022 (HealthDay News) — One in nine people with wet age-related macular degeneration (AMD) are skipping appointments for sight-saving eye injections, according to a study presented at the annual meeting of the American Academy of Op…
Learn MoreHigh Framingham Risk Score Seen for Women With History of Migraine
THURSDAY, Oct. 6, 2022 (HealthDay News) — High Framingham risk score (FRS) categories are seen among women with a history of migraine, but not for those with active migraine at baseline or during follow-up, according to a study published online Aug. …
Learn MoreTreatment Sequence Studied for Advanced BRAF-Mutant Melanoma
THURSDAY, Oct. 6, 2022 (HealthDay News) — For patients with treatment-naive BRAFv600 mutant metastatic melanoma, treatment first with combination nivolumab/ipilimumab yields better overall survival than dual BRAF/MEK inhibition with dabrafenib/tramet…
Learn MoreLate-Night Meals Especially Bad for Weight Gain: Study
THURSDAY, Oct. 6, 2022 (HealthDay News) — Your fondness for midnight snacks has caused you to pack on the pounds over the years, and now researchers have a better understanding of why.While late-night eating has long been linked with an increased ris…
Learn MoreAHA News: He Ran a 10K, Went Into Heart Failure and Got a New Heart – All in a Few Weeks
THURSDAY, Oct. 6, 2022 (American Heart Association News) — Several days after running a 10K event in Atlanta in 2019, Arthur Vaughn found himself breathless simply walking across the room.Vaughn’s primary care physician recommended he see a cardiolog…
Learn MoreAAP Addresses Safety for Children in Emergency Care Settings
THURSDAY, Oct. 6, 2022 (HealthDay News) — All emergency departments should understand the unique safety issues related to children, according to a policy statement and accompanying technical report released by the American Academy of Pediatrics, Amer…
Learn More